Colorectal cancer (CRC) is one of the most preventable cancers with early detection, but remains the second leading cause of cancer death in Canada and the United States. Given the high impact of CRC...
Vastcon Inc.
10 enregistrements totalisant 674,826.00 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.
Intégrer ce graphique
Par ministère
| Conseil national de recherches Canada | $674,826 | 10 enregistrements |
Enregistrements
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small-and medium-sized enterprises that are unable to access existing COVID-19 business support.
Estrogen Receptor (ER) Positive breast cancer is the most common type and can be effectively treated with endocrine therapy. However, the major challenge is the endocrine therapy resistance and breast...
This project entails production and purification of monoclonal antibodies which will be used for the development of diagnostics.
VastCon has discovered unique molecular signatures in blood that could detect genetic hereditary colorectal cancers. This project is aimed at developing a screening test for genetic hereditary colorec...
The funding provided by the IAP is to assist innovative, early stage small-and-medium-sized enterprises that are unable to access existing COVID-19 business support.
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.